Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments

[1]  M. Forster,et al.  Immune Checkpoint Inhibition in Head and Neck Cancer , 2018, Front. Oncol..

[2]  M. Boutros,et al.  β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells , 2018, Scientific Reports.

[3]  James S. Lawson,et al.  Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV) , 2018, Front. Oncol..

[4]  Y. Okamoto,et al.  Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma , 2017, Oncotarget.

[5]  T. McGaha,et al.  Type I Interferon in Chronic Virus Infection and Cancer. , 2017, Trends in immunology.

[6]  N. Wentzensen,et al.  Somatic Host Cell Alterations in HPV Carcinogenesis , 2017, Viruses.

[7]  J. Lunceford,et al.  PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer , 2017, Clinical Cancer Research.

[8]  Seiji Nakamura,et al.  Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition. , 2017, Oral oncology.

[9]  Z. Herceg,et al.  Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas , 2017, Genome Medicine.

[10]  Amy L. Olex,et al.  Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma , 2017, Oncotarget.

[11]  M. Boutros,et al.  Wnt signaling in cancer , 2016, Oncogene.

[12]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[13]  Adrian V. Lee,et al.  Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types. , 2016, Cell reports.

[14]  D. Rieke,et al.  Targeted Therapy of Head and Neck Cancer , 2016, Oncology Research and Treatment.

[15]  A. Hakimi,et al.  The head and neck cancer immune landscape and its immunotherapeutic implications. , 2016, JCI insight.

[16]  P. Laurent-Puig,et al.  Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression , 2016, Genome Biology.

[17]  E. Mroz,et al.  Intra-tumor heterogeneity in head and neck cancer and its clinical implications , 2016, World journal of otorhinolaryngology - head and neck surgery.

[18]  Maureen A. Sartor,et al.  Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures , 2016, Clinical Cancer Research.

[19]  Chao Li,et al.  LY 6 K promotes cervical cancer growth , invasion and migration through regulating VEGFA , 2016 .

[20]  J. Zucman‐Rossi,et al.  Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers. , 2016, Advances in immunology.

[21]  Tian Wang,et al.  Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data. , 2015, Genetics and molecular research : GMR.

[22]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[23]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[24]  G. Sledge,et al.  Targeted Therapy for Cancer in the Genomic Era. , 2015, Cancer journal.

[25]  Chung-Pin Li,et al.  Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial , 2015, Oncotarget.

[26]  Ruedi Aebersold,et al.  A Mass Spectrometric-Derived Cell Surface Protein Atlas , 2015, PloS one.

[27]  D. Cheresh,et al.  Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. , 2015, Trends in cell biology.

[28]  J. Xiang,et al.  HER2-directed therapy: current treatment options for HER2-positive breast cancer , 2015, Breast Cancer.

[29]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[30]  F. Buonaguro,et al.  Antigen-specific vaccines for cancer treatment , 2014, Human vaccines & immunotherapeutics.

[31]  Thomas Lengauer,et al.  Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.

[32]  Petar Stojanov,et al.  Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas , 2014, Clinical Cancer Research.

[33]  William Lee,et al.  Unraveling the molecular genetics of head and neck cancer through genome-wide approaches , 2014, Genes & diseases.

[34]  E. Andres Houseman,et al.  Reference-free cell mixture adjustments in analysis of DNA methylation data , 2014, Bioinform..

[35]  E. Houseman,et al.  Normal Cell-Type Epigenetics and Breast Cancer Classification: A Case Study of Cell Mixture–Adjusted Analysis of DNA Methylation Data from Tumors , 2014, Cancer informatics.

[36]  Joel H. Saltz,et al.  Research and applications: Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data , 2013, J. Am. Medical Informatics Assoc..

[37]  R. Ward,et al.  The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis , 2013, International Journal of Cancer.

[38]  Thomas M. Harris,et al.  Unique DNA Methylation Loci Distinguish Anatomic Site and HPV Status in Head and Neck Squamous Cell Carcinoma , 2013, Clinical Cancer Research.

[39]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[40]  Yi Li,et al.  A mixture model for expression deconvolution from RNA-seq in heterogeneous tissues , 2013, BMC Bioinformatics.

[41]  A. Chatterjee,et al.  Integrins and metastasis , 2013, Cell adhesion & migration.

[42]  J. Khan,et al.  Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers , 2012, Front. Oncol..

[43]  Sukjoon Yoon,et al.  The Regulatory Mechanism of the LY6K Gene Expression in Human Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[44]  J. Kao,et al.  Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer , 2012, Immunologic Research.

[45]  A. Funnell,et al.  Holding Tight: Cell Junctions and Cancer Spread. , 2012, Trends in cancer research.

[46]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Ralf Herwig,et al.  ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..

[48]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[49]  Ashley L. Buchanan,et al.  Docetaxel and irinotecan in recurrent or metastatic head and neck cancer , 2009, Cancer.

[50]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[51]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[52]  L. Turek,et al.  P16INK4a expression, human papillomavirus, and survival in head and neck cancer. , 2008, Oral oncology.

[53]  S. Keam,et al.  Bevacizumab: a review of its use in metastatic colorectal cancer. , 2008, Drugs.

[54]  Y. Miyagi,et al.  Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. , 2007, Cancer research.

[55]  C. Ragin,et al.  The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus , 2007, Journal of dental research.

[56]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[57]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Zanetti,et al.  CD8 T cell priming by B lymphocytes is CD4 help dependent , 2005, European journal of immunology.

[59]  M. Hellmich,et al.  Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types , 2004, The Pharmacogenomics Journal.

[60]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[61]  G. Snow,et al.  Characterization of the human Ly‐6 antigens, the newly annotated member Ly‐6K included, as molecular markers for head‐and‐neck squamous cell carcinoma , 2003, International journal of cancer.

[62]  C. Fenoglio-Preiser,et al.  beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. , 2002, Cancer research.

[63]  A. Olshan,et al.  Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology , 1998, Head & neck.